- Home
- EDIT vs NCTY Comparison
EDIT vs NCTY Comparison
Compare EDIT & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- NCTY
- Stock Information
- Founded
- EDIT 2013
- NCTY 1999
- Country
- EDIT United States
- NCTY China
- Employees
- EDIT N/A
- NCTY N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- NCTY Business Services
- Sector
- EDIT Health Care
- NCTY Consumer Discretionary
- Exchange
- EDIT Nasdaq
- NCTY Nasdaq
- Market Cap
- EDIT 156.5M
- NCTY 156.7M
- IPO Year
- EDIT 2016
- NCTY 2004
- Fundamental
- Price
- EDIT $2.25
- NCTY $8.08
- Analyst Decision
- EDIT Buy
- NCTY
- Analyst Count
- EDIT 13
- NCTY 0
- Target Price
- EDIT $6.73
- NCTY N/A
- AVG Volume (30 Days)
- EDIT 2.4M
- NCTY 97.2K
- Earning Date
- EDIT 08-06-2025
- NCTY 01-01-0001
- Dividend Yield
- EDIT N/A
- NCTY N/A
- EPS Growth
- EDIT N/A
- NCTY N/A
- EPS
- EDIT N/A
- NCTY N/A
- Revenue
- EDIT $35,837,000.00
- NCTY $15,305,175.00
- Revenue This Year
- EDIT N/A
- NCTY N/A
- Revenue Next Year
- EDIT N/A
- NCTY N/A
- P/E Ratio
- EDIT N/A
- NCTY N/A
- Revenue Growth
- EDIT N/A
- NCTY N/A
- 52 Week Low
- EDIT $0.91
- NCTY $5.75
- 52 Week High
- EDIT $6.05
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- EDIT 63.76
- NCTY 34.64
- Support Level
- EDIT $2.05
- NCTY $7.41
- Resistance Level
- EDIT $2.55
- NCTY $8.25
- Average True Range (ATR)
- EDIT 0.23
- NCTY 0.71
- MACD
- EDIT 0.03
- NCTY -0.16
- Stochastic Oscillator
- EDIT 66.29
- NCTY 22.56
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.